Skip to main content

Table 7 Summary of changes in total bilirubin and alanine aminotransferase during the first episode

From: Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial

 

ASAQ

AL

p-value

Total bilirubin mg/dL)

   

   Day 0

(n = 184)

(n = 182)

 

Mean ± SD

1.46 ± 0.99

1.50 ± 1.51

0.796

Range

0.02-5.52

0.01-17.27

 

   Day 7

(n = 182)

(n = 180)

 

Mean ± SD

0.83 ± 1.45

0.80 ± 1.04

0.825

Range

0.03-19.25

0.04-13.18

 

   Day 28

(n = 181)

(n = 175)

 

Mean ± SD

0.60 ± 0.35

0.80 ± 1.04

1.000

Range

0.01-2.33

0.03-2.57

 

ALT (UI/L)

   

   Day 0

(n = 184)

(n = 182)

 

Mean ± SD

29.2 ± 30.0

27.8 ± 29.8

0.505

Range

2-199

1-217

 

   Day 7

(n = 183)

(n = 181)

 

Mean ± SD

22.4 ± 15.7

25.1 ± 27.4

0.877

Range

1-95

1-218

 

   Day 28

(n = 181)

(n = 175)

 

Mean ± SD

20.9 ± 14.9

19.5 ± 15.9

0.053

Range

1-110

3-99